Abstract

Today the U.S. Food and Drug Administration (FDA) announced measures to resolve the shortages of two cancer drugs — including methotrexate, a drug vital in the treatment of childhood leukemia — and issued draft guidance requirements to help reduce shortages overall. To increase availability of

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call